| P/E (FY) | — | Sales (TTM) | $1.0M |
| Earnings (TTM) | -$10.9M | ROE | −303.80% |
| Net Margin | −1018.07% | ROIC | — |
| Debt / Equity | 0.00 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | −13.28% |
| Market Cap | $6.7M | Trading Days | 2988 |
| 52W High | 6.78 |
| 52W Low | 1.40 |
| % Off High | −76.99% |
| YTD | −59.59% | 1Y | −43.88% |
| 3Y | −99.50% | 5Y | −100.00% |
| 10Y | −99.99% | Since incept. (ann.) | −59.14% |
Product 72% · Grant And Contract 28%
| Ann. Volatility (1Y) | 86.68% | Ann. Volatility (3Y) | 159.60% |
| Sharpe (1Y) | −0.25 | Sharpe (3Y) | −0.42 |
| Max Drawdown (1Y) | −74.59% | Max Drawdown (3Y) | −99.55% |
| Beta (3Y, vs SPY) | 0.53 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| NVNO | enVVeno Medical Corp | $6.9M | — |
| VVOS | Vivos Therapeutics, Inc. | $5.8M | — |
| SNOA | Sonoma Pharmaceuticals, Inc. | $5.5M | — |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | $8.4M | — |
| CODX | Co-Diagnostics, Inc. | $5.1M | — |
| PFSA | Profusa, Inc. | $4.8M | — |
| ADGM | Adagio Medical Holdings, Inc. | $9.9M | — |
| NXGL | NEXGEL, INC. | $4.0M | — |
| ICU | SeaStar Medical Holding Corp | $13.7M | — |
| OSRH | OSR Health, Inc. | $16.0M | — |
| BTCY | BIOTRICITY INC. | $2.3M |
| — |
| RVP | RETRACTABLE TECHNOLOGIES INC | $20.1M | — |
